|
|
Vaccine Detail
|
MAGE-A12:170-178 |
| Vaccine Information |
- Vaccine Name: MAGE-A12:170-178
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007635
- Type: peptide
- Status: Research
- Antigen: HLA-Cw*0702
- Immunization Route: Intramuscular injection (i.m.)
|
| Host Response |
|
Human Response
- Vaccine Immune Response Type: VO_0003057
- Immune Response: No convincing evidence of enhancement of the systemic immune response against MAGE-A12:170–178 could be documented (Bettinotti et al., 2003).
|
| References |
Bettinotti et al., 2003: Bettinotti MP, Panelli MC, Ruppe E, Mocellin S, Phan GQ, White DE, Marincola FM. Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702-associated epitope MAGE-A12:170-178. International journal of cancer. Journal international du cancer. 2003; 105(2); 210-216. [PubMed: 12673681].
|
|
